1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Smoking reduces the efficacy of belimumab in mucocutaneous lupus
- Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis
- DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus
- A rare regulatory variant in the MEF2D gene affects gene regulation and splicing and is associated with a SLE sub-phenotype in Swedish cohorts
- 2017
- Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus
- A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus
- Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis
- Novel risk genes for systemic lupus erythematosus predicted by random forest classification
- 2016
- Platelet-derived S100A8/A9 and cardiovascular disease in systemic lupus erythematosus.
- Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.